Neuropsychiatric Symptoms in Lewy Body Disease: Monoaminergic Activity and Resting State Networks
Objective: Investigating how neuropsychiatric symptoms (NPS)—depression, anxiety, and apathy—relate to functional connectivity between monoaminergic nuclei and the limbic network (LN), default mode network (DMN), and…Psychiatric Profiles in Parkinson: A Cluster Analysis of Cognitive Performance
Objective: To compare the differences in cognitive domains assessed with the Montreal Cognitive Assessment (MoCA) among the different psychiatric profiles clusters using the Symptom Checklist-90-Revised…Escitalopram for Depression and Motor Symptoms in Parkinson’s Disease: A Systematic Review and Meta‑analysis
Objective: To evaluate the efficacy of escitalopram versus placebo for depressive symptoms, motor severity, and quality of life (QoL) in Parkinson’s disease (PD). Background: Depression…Brain-Derived Neurotrophic Factor as a Biomarker of Depression in Parkinson’s Disease
Objective: To determine whether peripheral neurodegeneration-related biomarker levels differ between patients with Parkinson’s disease (PD) with and without depression and to identify biomarkers associated with…Exploring the Relationship Between Circadian Disruption, Depression and Suicidal Ideation in People with Huntington’s Disease (Mind & Clock Study)
Objective: To examine the relationship between circadian and sleep disruptions and depressive symptoms and suicidal ideation in people with Huntington’s Disease (PwHD) using scale-based and…Motor and Non-Motor Symptoms Across Psychiatric Profiles in Parkinson’s: A Cluster Analysis
Objective: To compare the differences in motor and non-motor symptoms assessed with the Movement Disorders Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) among the different…Analysis of Genetic Variants Associated with Parkinson’s Disease and Depression
Objective: The objective of this study was to evaluate the effect of SNPs in BDNF on depressive symptomatology in a sample of individuals with PD.…Functional Dyskinesia in a Patient with Parkinson’s Disease: A Diagnostic and Therapeutic Challenge
Objective: The coexistence of Parkinson’s disease (PD) and functional movement disorders (FMD) is increasingly recognized but remains underdiagnosed. Functional dyskinesia, a subtype of FMD, can…Prevalence and clinical predictors of depressive symptoms in Parkinson’s Disease: an analysis from the Global Parkinson’s Genetics Program
Objective: To estimate the prevalence and distribution of depressive symptoms in PwP and identify demographic and clinical factors associated with depression across European cohorts available…Metabolomic profile as a biomarker of non-motor symptoms severity in patients with Parkinson’s disease
Objective: To investigate possible associations between serum metabolomic profiles and non-motor symptoms (NMS) frequency and intensity in PD patients Background: Metabolomic studies are providing growing…
- 1
- 2
- 3
- …
- 38
- Next Page »